Background: Asbestos processing began in Mexico in the 1930s and continues to this day. Mesothelioma is a lethal cancer associated with asbestos exposure, which appears after an induction period of 20-50 years. Given this scenario, an updated description of mortality trends from mesothelioma in Mexico is needed.
Methods: Mortality data from mesothelioma in Mexico were retrieved for the period 1998-2022. Age-standardized mortality rates (World standard population) were computed per million according to sex, year, and state. Mortality trends were analysed through joinpoint regression analyses, estimating the annual percentage change in mesothelioma mortality for the studied period.
Results: In the period 1998-2022, 5472 people died from mesothelioma. Overall, 67% of deaths corresponded to males, and age-specific mortality rates were highest for people aged ≥55 years. Age-standardized mortality rates increased from 2.53 per million in 1998 to 3.46 per million in 2022, with the largest increase between 1998 and 2008 with an annual percentage increase of 4.34% (95% confidence interval [95% CI] 2.09, 11.86). Among males, an increase in mesothelioma mortality was observed in a 21-year period (annual percentage increase of 4.32% [95% CI 1.56, 19.35] during 1998-2008 and 0.58% [95% CI -1.72, 3.93] during 2008-2019). Higher age-standardized mortality rates were observed in the northern states and in central Mexico.
Conclusion: Mortality from mesothelioma increased over the period 1998-2022 in Mexico. Special attention should be given to regions with the highest death rates, and Mexico should promote policies towards a complete ban of asbestos.
Background: The rising rates of multimorbidity have important implications for individuals, caregivers, and healthcare systems. Research from North America documents that more recent birth cohorts of older adults are experiencing higher levels of mortality and multimorbidity than earlier cohorts.
Methods: The present study utilizes data from the English Longitudinal Study on Ageing and the Survey of Health, Ageing, and Retirement in Europe and longitudinal mixed-effects models to examine inter-cohort trends in multimorbidity in England and Europe between ages 40 and 85 years. We also examine whether population shifts in socio-demographic characteristics, health behaviours, or specific chronic conditions explain the cohort divergence.
Results: There are significant birth cohort differences in age-related trajectories of chronic disease accumulation between ages 40 and 85 years in both populations. More recent cohorts born after World War II experienced significantly more chronic disease than did those born in early cohorts at equivalent ages. In England and Europe, members of the 1946-1950 cohort had accumulated an average of one condition at ages of ∼65 and ∼70 years, respectively, while those born in 1915-1923 did so at ages of ∼80 and ∼85, respectively. Socio-demographic and behavioural factors are related to individual trajectories of chronic disease accumulation, but do not attenuate cohort divergence. The greatest divergence was observed for arthritis, diabetes, and cardiovascular disease. Within Europe, cohort divergence further varies by region.
Conclusion: Results echo North American patterns of a more rapid accumulation of multimorbidity among recent cohorts. Patterns persist after adjustment for socio-demographic and behavioural profiles, suggesting that the drivers of birth cohort divergence lie with broader structural forces (e.g. shifting epidemiologic environment and diagnostic processes) rather than individual-level characteristics.

